2010
DOI: 10.1152/ajpcell.00216.2010
|View full text |Cite
|
Sign up to set email alerts
|

Upregulation of nuclear factor-κB expression by SLURP-1 is mediated by α7-nicotinic acetylcholine receptor and involves both ionic events and activation of protein kinases

Abstract: SLURP-1 (secreted mammalian Ly-6/urokinase plasminogen activator receptor-related protein-1) is a novel auto/paracrine cholinergic peptide that can bind to α(7)-nicotinic acetylcholine receptor (nAChR), a high Ca(2+)-permeable ion channel coupled to regulation of nuclear factor-κB (NF-κB) expression. Elucidation of intracellular signaling events elicited by SLURP-1 is crucial for understanding the molecular mechanism of functioning of this novel hormone-like peptide that alters vital cell functions and can pro… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
51
1

Year Published

2010
2010
2020
2020

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 59 publications
(53 citation statements)
references
References 82 publications
(77 reference statements)
1
51
1
Order By: Relevance
“…The natural ligand(s) responsible for CHRFAM7A activation is presumed to include acetylcholine, but its ligand selectivity is not known compared with other nAChRs, each of which have been described extensively (68). Normally, acetylcholine is thought to be the intrinsic ligand that activates the cell surface α7nAChR homopentameric channel, but there are numerous alternative ligands including choline, nicotine and even peptide hormone-like ligands (69)(70)(71)(72)(73) that can activate α7nAChR. The discovery of an alternative α7nAChR in human leukocytes raises the possibility that heteropentamers composed of CHRNA7 and CHRFAM7A proteins could modulate the cellular immune response to proinflammatory challenges (see Figure 6).…”
Section: Resultsmentioning
confidence: 99%
“…The natural ligand(s) responsible for CHRFAM7A activation is presumed to include acetylcholine, but its ligand selectivity is not known compared with other nAChRs, each of which have been described extensively (68). Normally, acetylcholine is thought to be the intrinsic ligand that activates the cell surface α7nAChR homopentameric channel, but there are numerous alternative ligands including choline, nicotine and even peptide hormone-like ligands (69)(70)(71)(72)(73) that can activate α7nAChR. The discovery of an alternative α7nAChR in human leukocytes raises the possibility that heteropentamers composed of CHRNA7 and CHRFAM7A proteins could modulate the cellular immune response to proinflammatory challenges (see Figure 6).…”
Section: Resultsmentioning
confidence: 99%
“…Evidence that ␣4␤2 receptors mediate this effect is based on using lobeline as a "selective ␣4␤2 antagonist" to distinguish nicotine's effect between these receptor subtypes at concentrations greater than 20 times lobeline's IC 50 for human ␣7 receptors expressed in oocytes (Briggs and McKenna, 1998)). Very recent work suggests that in certain circumstances, nonphosphorylated STAT3 regulates NF-B activity and cytokine production in macrophages (Peñ a et al, 2010) and that the cholinergic peptide SLURP-1 modulates ␣7-JAK2-mediated up-regulation of NF-B in keratinocytes (Chernyavsky et al, 2010). Further work is clearly required to sort out how JAK2-STAT3 signaling can be both pro-and anti-inflammatory and both block and stimulate NF-B signaling, depending on context.…”
Section: Discussionmentioning
confidence: 99%
“…In this capacity, the a7nAChR can act as a ligand-gated ion channel or stimulate intrinsic signal transduction and metabotropic activities (1,(26)(27)(28). In view of the significance of a7nAChRs to epithelial biology and the observation that human-specific genes are disproportionately implicated in complex disease (29), it is remarkable that little attention has been paid to the 1998 discovery that there exists a human-specific gene called CHRFAM7A (gene-encoding dup-a7-nicotinic acetylcholine receptor), which can modify a7nAChR responsiveness (30).…”
mentioning
confidence: 99%